Los Angeles 2017

May 5-10, 2017

Navigating Diagnostics, Therapies, and MIGS for Glaucoma Patients

Supported by educational grants from Alcon Laboratories Inc., Allergan, Bausch + Lomb, and Glaukos Corporation. Additional grants pending.

 

Los Angeles

Friday, May 5, 2017

City/State/Country: Los Angeles, CA USA
Venue: Los Angeles Convention Center
Room Location: West Hall B
Registration and Breakfast: 6:00 AM - 6:30 AM
Program: 6:30 AM - 7:30 AM

Faculty

Moderator
Douglas J. Rhee, MD

Faculty
Robert J. Noecker, MD
Thomas D. Patrianakos, MD
Nathan M. Radcliffe, MD

 

Preliminary Program

 

6:30 AM   Welcome and Introductions – Douglas J. Rhee, MD

6:42 AM   Diagnostic Protocols to Guide Surgical Management – Thomas D. Patrianakos, MD

6:54 AM   Beyond PGA Monotherapy: Considering Adjunctive or Alternative Combination Therapies – Robert J. Noecker, MD, MBA

7:06 AM   MIGS Options Across the Spectrum from Early to Advanced Glaucoma – Nathan M. Radcliffe, MD

7:18 AM   Panel Discussion – Douglas J. Rhee, MD

7:30 AM   Conclude

 

 

Target Audience
This educational activity is intended for ophthalmologists.

Educational Objectives
Ophthalmologists attending this meeting will:
•     Identify the diagnostic protocols necessary to evaluate fluid drainage and optic nerve structure and function to guide glaucoma therapy decisions
•     Analyze the risks and benefits of combination therapy
•     Describe how and when to integrate new MIGS options from early to advanced glaucoma

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and EyeWorld news magazine. ASCRS is accredited by the ACCME to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of this CME activity.

Designation Statement
The American Society of Cataract and Refractive Surgery designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™
Physicians should claim only credit commensurate with the extent of their participation in the activity. 
Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™

Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits.

Notice of Off-Label Use Presentations
This program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he/she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.

ADA/Special Accommodations
ASCRS fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in this educational program who requires special accommodation or services should contact an ASCRS or EyeWorld staff member onsite.